- Home
- AMWD vs ORIC Comparison
AMWD vs ORIC Comparison
Compare AMWD & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMWD
- ORIC
- Stock Information
- Founded
- AMWD 1980
- ORIC 2014
- Country
- AMWD United States
- ORIC United States
- Employees
- AMWD N/A
- ORIC N/A
- Industry
- AMWD Forest Products
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- AMWD Basic Materials
- ORIC Health Care
- Exchange
- AMWD Nasdaq
- ORIC Nasdaq
- Market Cap
- AMWD 907.4M
- ORIC 938.2M
- IPO Year
- AMWD N/A
- ORIC 2020
- Fundamental
- Price
- AMWD $67.18
- ORIC $9.74
- Analyst Decision
- AMWD Buy
- ORIC Strong Buy
- Analyst Count
- AMWD 4
- ORIC 9
- Target Price
- AMWD $83.33
- ORIC $17.25
- AVG Volume (30 Days)
- AMWD 267.3K
- ORIC 1.3M
- Earning Date
- AMWD 08-26-2025
- ORIC 08-12-2025
- Dividend Yield
- AMWD N/A
- ORIC N/A
- EPS Growth
- AMWD N/A
- ORIC N/A
- EPS
- AMWD 6.50
- ORIC N/A
- Revenue
- AMWD $1,709,585,000.00
- ORIC N/A
- Revenue This Year
- AMWD N/A
- ORIC N/A
- Revenue Next Year
- AMWD $4.03
- ORIC N/A
- P/E Ratio
- AMWD $10.30
- ORIC N/A
- Revenue Growth
- AMWD N/A
- ORIC N/A
- 52 Week Low
- AMWD $50.00
- ORIC $3.90
- 52 Week High
- AMWD $104.28
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- AMWD 65.55
- ORIC 46.26
- Support Level
- AMWD $60.92
- ORIC $9.32
- Resistance Level
- AMWD $65.97
- ORIC $10.06
- Average True Range (ATR)
- AMWD 3.08
- ORIC 0.48
- MACD
- AMWD 0.40
- ORIC -0.02
- Stochastic Oscillator
- AMWD 97.46
- ORIC 57.46
About AMWD American Woodmark Corporation
American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.